Onkologie. 2012:6(5):252-256

Brachytherapy of head and neck tumors

Jiří Petera
Klinika onkologie a radioterapie, FN Hradec Králové

Brachytherapy is a method of radiation treatment, when the radioactive sources are directly applicated into the tumor region. Brachytherapy

allows to deliver high doses to the tumor in a short time with excellent local tumor control. The largest experience was achieved

with continual low dose rate brachytherapy (0.4–2Gy/hr) and manual insertion of sources. Recently this method was mostly replaced by

automatic afterloading devices and high dose rate (> 12Gy/hr) fractionated treatment. Brachytherapy can be used in early stages of head

and neck cancer as a sole treatment method. The advantage in comparison with surgery is a better functional and cosmetic outcome

and in comparison with external beam radiotherapy a better tumor control and absence of xerostomia. In locally advanced tumors

brachytherapy can be used for dose escalation of external beam radiotherapy. Brachytherapy is also useful for salvage treatment of

recurrences after previous radiotherapy. Classical indications are oral cancer, oropharyngeal and nasopharyngeal tumors. Despite technological

advances of external beam radiotherapy brachytherapy remains a very important treatment method in head and neck tumors.

Keywords: brachytherapy, head and neck cancer

Published: November 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petera J. Brachytherapy of head and neck tumors. Onkologie. 2012;6(5):252-256.
Download citation

References

  1. Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, eds. The GEC ESTRO handbook of brachytherapy. Leuven, Belgium, 2002.
  2. Guinot JL, Arribas L, Chust ML, et al. Lip cancer treatment with high dose rate brachytherapy. Radiother Oncol 2003; 69: 113-115. Go to original source... Go to PubMed...
  3. Inoue T, Inoue T, Yamazaki H, Koizumi M. High dose rate versus low dose rate intersticial radiotherapy for carcinoma of the floor of mouth. Int J Radiat Oncol Biol Phys 1998; 41: 53-58. Go to original source... Go to PubMed...
  4. Gerbaulet A, Pernot M. Le carcinome epidermoide de la face interne de joue. A propos de 748 malades. J Eur Radiother 1985; 6: 1-4.
  5. Petera J, Doležel M, Jirousek Z, Tuček L, Bedrošová J, Frgala T. High dose rate brachytherapy in the treatment of oral cancer - the preliminary one institution experience. Neoplasma 2006; 53: 232-236. Go to PubMed...
  6. Tucek L, Petera J, Sirak I, et al. Hyperfractionated high-dose rate brachytherapy in the treatment of oral tongue cancer. Rep Pract Oncol Radiother 2011; 16: 239-243. Go to original source... Go to PubMed...
  7. Mazeron JJ, Crook JM, Benck V, et al. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue. Int J Radiat Oncol Biol Phys 1990; 19: 1369-1376. Go to original source... Go to PubMed...
  8. Yamazaki H, Inoue T, Yoshida K, et al. Brachytherapy for early tongue cancer: low dose rate to high dose rate. J Radiat Res 2003; 44: 37-40. Go to original source... Go to PubMed...
  9. Guinot JL, Santos M, Tortajada MI. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Brachytherapy 2010; 9: 227-234. Go to original source... Go to PubMed...
  10. Nose T, Koizumi M, Nishiyama K. High dose rate interstitial brachytherapy for oropharyngeal carinoma: results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phys 2004; 59: 983-891. Go to original source... Go to PubMed...
  11. Levendag P, Nijdam W, Noever I. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequale and performance status: can we obtain better sparing? Int J Radiat Oncol Biol Phys 2004; 59: 713-724. Go to original source... Go to PubMed...
  12. Wang CC. Carcinoma of the nasopharynx. Radiation Therapy for head and neck naoplasms. Third edition. Wiley-Liss, New York 1994: 257-260.
  13. Levendag PC, Lagerwaard FJ, dePan C, et al. High dose, high precision treatment oprions for boosting cancer of the nasopharynx. Radiother Oncol 2002; 63: 67-74. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.